| Literature DB >> 27816116 |
Sung-Han Yoon1, Young-Hak Kim2, Dong Hyun Yang3, Jae-Hyung Roh1, Eun Young Lee1, Pil Hyung Lee1, Daisuke Sugiyama4, Mineok Chang1, Jung-Min Ahn1, Won Jin Choi3, Joon-Won Kang3, Tae-Hwan Lim3, Joon Bum Kim5, Sung-Ho Jung5, Cheol Hyun Chung5, Suk Jung Choo5, Jae Won Lee5, Soo-Jin Kang1, Duk-Woo Park1, Seung-Whan Lee1, Cheol Whan Lee1, Seong-Wook Park1, Seung-Jung Park1.
Abstract
Coronary computed tomography angiography is widely used to evaluate the graft patency, but information on the progression of native-vessel disease remains limited. We sought to evaluate the impact of bypass grafting on native-vessel progression after coronary artery bypass grafting. We evaluated new native-vessel occlusion defined as occlusion length ≥15 mm as a surrogate marker of native-vessel progression. We evaluated 911 patients with 2,271 nonoccluded vessels who underwent coronary artery bypass grafting and received follow-up coronary computed tomography angiography. Over a mean follow-up period of 4.7 years, the new occlusion rates were 9.2% for left anterior descending artery (LAD), and 13.9% for non-LAD, respectively. For non-LAD, new occlusion rate of vessels with bypass grafts was higher compared to those without bypass graft regardless of baseline native-vessel stenosis (intermediate stenosis: 8.6% vs 1.7%, p <0.001; severe stenosis: 20.5% vs 9.9%, p = 0.003). Furthermore, new occlusion rate of vessels with venous graft was the highest, followed by vessels with arterial graft and vessels without bypass graft, regardless of baseline stenosis (intermediate stenosis: 11.1% vs 5.2% vs 1.7%, p <0.001; severe stenosis: 23.7% vs 15.9% vs 9.9%, p <0.001). By multivariate analysis, bypass grafting was associated with new native-vessel occlusion for non-LAD (odds ratio 3.04, 95% confidence interval 1.79 to 5.14; p <0.001). Bypass graft was associated with new native-vessel disease progression regardless of baseline stenosis. In conclusion, the decision to bypass or leave a native vessel with intermediate stenosis should cautiously be considered.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27816116 DOI: 10.1016/j.amjcard.2016.09.011
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778